ARCHIVES

Investigational Drug Radium-223 Chloride Improved Overall Survival By 44 Percent

This article is from The Cancer Letter archive.

Vol. 34 No. 9 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

Nevins Reverses Position, Claims Potti Manipulated Data For Basis of Clinical Trials

February 17, 2012

NCI-Approved CTEP Trials For The Month of June

June 29, 2012

Tamoxifen Offers Long-Term Benefits For Prevention

March 30, 2007

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999

Lederle Scientists Report Powerful New Anticancer Agent

July 31, 1987

In Brief: Administration Backs Down On a Attempt To Kill General Research Support, Will Try To Modify It

November 1, 1974